Fallopian Tube Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian; Fallopian Tube; Primary Peritoneal Cancer Interventions: Drug: Paclitaxel/Bev (control); Drug: Paclitaxel/Bev + ZA (experimental) Sponsors: M.D. Anderson Cancer Center; Gateway for Cancer Research; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2021 Category: Research Source Type: clinical trials
